Q2 2021 Holdings
Filed 2021-08-16 | 160 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $295.9M | 6,920,600 | 24.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $165.8M | 6,073,850 | 13.9% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $136.9M | 6,223,019 | 11.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $131.5M | 1,167,500 | 11.0% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $93.0M | 5,477,958 | 7.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $78.7M | 6,069,032 | 6.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $58.9M | 447,859 | 4.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $56.5M | 2,996,876 | 4.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $29.5M | 1,146,145 | 2.5% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $28.7M | 848,503 | 2.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $23.3M | 67,400 | 2.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $21.5M | 8,053,298 | 1.8% |
| Alector Inc(ALEC) | COM | 014442107 | $12.7M | 611,478 | 1.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $11.9M | 407,047 | 1.0% |
| Cvrx Inc(CVRX) | COM | 126638105 | $11.2M | 400,000 | 0.9% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.6M | 1,513,168 | 0.8% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $8.2M | 150,000 | 0.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $6.4M | 362,000 | 0.5% |
| Adagene Inc(ADAG) | ADS | 005329107 | $3.7M | 275,000 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $498.1K | 6,044,266 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $301.7K | 4,515,400 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $297.4K | 13,944,680 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $290.3K | 3,732,400 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $287.4K | 10,039,691 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $273.6K | 2,922,155 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $270.0K | 8,740,887 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $250.4K | 7,330,423 | 0.0% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $249.9K | 11,895,652 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $233.6K | 2,057,800 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $214.8K | 1,065,400 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $204.2K | 1,264,200 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $184.2K | 2,361,327 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $172.9K | 6,645,100 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $156.1K | 389,700 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $152.4K | 1,227,400 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $148.3K | 335,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $128.4K | 139,600 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $128.2K | 335,700 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $127.0K | 297,400 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $126.7K | 935,700 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $120.7K | 3,297,301 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $119.8K | 1,231,115 | 0.0% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $118.8K | 72,873,494 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $116.7K | 1,126,400 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $106.8K | 3,426,325 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $102.5K | 7,884,870 | 0.0% |
| Neuropace Inc(NPCE) | COM | 641288105 | $95.5K | 4,012,281 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $92.2K | 6,962,899 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $89.6K | 3,847,929 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $87.6K | 337,400 | 0.0% |